Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravitreal Low Molecular Weight Heparin and 5‐Fluorouracil for the Prevention of Proliferative Vitreoretinopathy Following Retinal Reattachment Surgery." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438361/2/Tobacco_packaging_design_for_reducing_tobacco_use_New. Accessed 19 April 2024.
Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/2/Tobacco_packaging_design_for_reducing_tobacco_use_New. Accessed April 19, 2024.
Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/2/Tobacco_packaging_design_for_reducing_tobacco_use_New
Intravitreal Low Molecular Weight Heparin and 5‐Fluorouracil for the Prevention of Proliferative Vitreoretinopathy Following Retinal Reattachment Surgery [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/2/Tobacco_packaging_design_for_reducing_tobacco_use_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
ID - 438361
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/2/Tobacco_packaging_design_for_reducing_tobacco_use_New
DB - Evidence Central
DP - Unbound Medicine
ER -